Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

On the Couch

On the Couch artwork

On the Couch with Scott Kirkland: Why EMVision is One to Watch

Aug 16, 202423 minAudio
ShareXLinkedInFacebookWhatsAppEmail

Welcome to another episode of 'On the Couch'. This occasional podcast series of chats with brokers, CEOs, and fund managers aims to give you an insight into the investing world. In this episode, Henry Jennings is joined by Scott Kirkland, CEO and Co-Founder at EMVision Medical Devices (ASX: EMV). Scott has held several senior sales positions, including Head of Client Sales at Quantcast, a US-based technology company, before establishing EMVision as a leader in innovative neurodiagnostic technology. In this episode they talk: What is EMV trying to achieve? Why is it important? What progress has EMV made with Emu and First Responder? How long do the trials take? When can we expect the first revenue? How is the cash position? What are the milestones and catalysts for investors in the next 12 months? Why should investors buy EMV? Disclaimer: This is general advice only and you should consult your financial adviser regarding any of the thoughts, ideas or insights in this podcast. Why not sign up for a free trial? Get access to expert insights and research and become a better investor. Use the promo code 'OTC24' for a discount on subscriptions 6 months and over. Subscribe now for in-depth market analysis, stock recommendations, investment and ideas strategies, and the suite of Marcus Today tools to manage your portfolio.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. On the Couch with Dr Samantha South (ASX: PAB): Repurposing an Established Drug for Delirium

    Nov 20, 202629 minAudio

    In this episode of On the Couch, Henry Jennings speaks with Dr Samantha South, CEO of Patrys (ASX: PAB). Samantha explains delirium, an acute brain dysfunction that can cause confusion, agitation and hallucinations, and...

    Credit the people on this episode

  2. On the Couch with Ryan MacNeill (ASX: EQR): Why Tungsten Is in Focus at IMARC 2026

    Nov 20, 202616 minAudio

    In this episode of On the Couch, Henry Jennings sits down with Ryan MacNeill, General Manager of Sales and Marketing at EQ Resources (ASX: EQR), at the International Mining and Resources Conference (IMARC) 2026....

    Credit the people on this episode

  3. On the Couch with Richard Morrow (ASX: LRT): Copper, Gold and Critical Minerals at IMARC 2026

    Nov 13, 202615 minAudio

    In this episode of On the Couch, Henry Jennings sits down with Richard Morrow, Director of Lowell Resources Funds Management, at the International Mining and Resources Conference (IMARC) 2026. Recorded live in the OnAir...

    Credit the people on this episode

  4. On the Couch with Jim McKerlie (ASX: IPT): From Explorer to Advanced Materials at IMARC 2026

    Nov 13, 202616 minAudio

    In this episode of On the Couch, Henry Jennings sits down with Jim McKerlie, Chairman of Impact Minerals (ASX: IPT), at the International Mining and Resources Conference (IMARC) 2026. Recorded live in the OnAir podcast...

    Credit the people on this episode

  5. On the Couch with David Newling (ASX: AR1): Why Queensland Copper Is Consolidating at IMARC 2026

    Nov 11, 202611 minAudio

    In this episode of On the Couch, Henry Jennings speaks with David Newling, Chairman of Austral Resources (ASX: AR1), at the International Mining and Resources Conference (IMARC) 2026. Recorded live in the OnAir podcast...

    Credit the people on this episode